All supplements

Supplement evidence

146 / 575Reproductive health

Chasteberry (Vitex)

View my plan

The short answer

Standardized extracts may improve premenstrual symptoms; fertility and other claims are less certain.

Evidence and scope
Conditional or population-specific

This status does not grade the ingredient for every goal, outcome, or person.

Important limitation
Benefit depends on the population, formulation, baseline status, and objective; results should not be generalized.
Before deciding
Key concern: Pregnancy, breastfeeding, fertility treatment, hormonal contraception, antipsychotics, and dopamine medicines require review.

01 / PRACTICAL GUIDE

Dose, absorption, and combinations

These are indication-specific reference or studied ranges—not a personalized prescription. Start with the objective, then check the form, label, medicines, and health conditions.

Reference range by objective
Premenstrual symptoms20–40 mg/day standardized extract in many trials

Reference or studied range—not a personalized prescription. The product label or a clinician may specify a different dose.

Dose source

More is not automatically better. A clinician or product label may specify a different amount.

Absorption / solubilityFormulation-dependent

Not usefully classified as a fat- or water-soluble vitamin; absorption depends on the salt, extract, delivery system, and meal.

How it is commonly taken

Take consistently at the same time daily.

Do not combine casually

Pregnancy, breastfeeding, fertility treatment, hormonal contraception, antipsychotics, and dopamine medicines require review.

Dose and use source

Dose and use links lead to primary or official source material. Search links are discovery tools, not proof that every returned paper applies.

02 / EVIDENCE

What the research says

We keep supportive, mixed, negative, safety, and contextual findings together. The headline never replaces the underlying papers.

1research papers in this ledger
3unique primary studies represented
520unique participants represented

These are audited counts for this JIVANA collection, not search-result totals. Participants are counted once when multiple papers use the same cohort; review papers are not added again to participant totals.

Open the research timelineResearch timeline

Entries are ordered by publication year. A study period appears only when the source reports it.

2019
Mixed or qualifiedPMID 31780016

Characterized Vitex agnus-castus extracts for premenstrual syndrome

Participants receiving the two characterized extracts were more likely to meet symptom-remission definitions than placebo, but only 3 of 21 identified trials were adequately characterized and reportable. Results cannot be generalized to other chasteberry products or fertility claims.

Study design and methods
Design
Meta-analysis of 3 randomized, double-blind, placebo-controlled trials meeting herbal-product reporting criteria
Population
520 women with premenstrual syndrome
Intervention
Characterized Vitex extracts Ze 440 or BNO 1095 versus placebo
Outcome
Remission or substantial reduction in total premenstrual symptom scores
Open research record
Unscreened discovery appendix—not evidence14 candidate publicationsSearch run: Aug 21, 2026

Complete for the displayed PubMed query at the search timestamp—not for all databases or every possible synonym. Candidates can be irrelevant, duplicate the same study, or report negative findings. They are never summed as evidence or participants until screened.

03 / SOURCES

Start with the source material

The live search is for discovery only. Search-result counts change and are not included in the audited totals above.

Recent PubMed discovery recordsDirect links to the first 12 records returned by the reproducible search. These are discovery candidates—not reviewed summaries or a count of supportive findings.
  1. Comparison of the Effects of Vitagnus, Soy, and Vitagnus-soy Capsules on Premenstrual Syndrome in University Students: A Randomized Clinical Trial.Partovi Golshan R, Moradi M, Rakhshandeh H et al. · 2025 · International journal of community based nursing and midwifery · PMID 39906250Open on PubMed
  2. Vitex agnus-castus in premenstrual syndrome: A meta-analysis of double-blind randomised controlled trials.Csupor D, Lantos T, Hegyi P et al. · 2019 · Complementary therapies in medicine · PMID 31780016Open on PubMed
  3. Vitex agnus castus for premenstrual syndrome and premenstrual dysphoric disorder: a systematic review.Cerqueira RO, Frey BN, Leclerc E et al. · 2017 · Archives of women's mental health · PMID 29063202Open on PubMed
  4. The treatment of premenstrual syndrome with preparations of Vitex agnus castus: a systematic review and meta-analysis.Verkaik S, Kamperman AM, van Westrhenen R et al. · 2017 · American journal of obstetrics and gynecology · PMID 28237870Open on PubMed
  5. Effects and treatment methods of acupuncture and herbal medicine for premenstrual syndrome/premenstrual dysphoric disorder: systematic review.Jang SH, Kim DI, Choi MS · 2014 · BMC complementary and alternative medicine · PMID 24410911Open on PubMed
  6. Dose-dependent efficacy of the Vitex agnus castus extract Ze 440 in patients suffering from premenstrual syndrome.Schellenberg R, Zimmermann C, Drewe J et al. · 2012 · Phytomedicine : international journal of phytotherapy and phytopharmacology · PMID 23022391Open on PubMed
  7. Therapeutic effect of Vitex agnus castus in patients with premenstrual syndrome.Zamani M, Neghab N, Torabian S · 2012 · Acta medica Iranica · PMID 22359078Open on PubMed
  8. [Psychic aspects of the premenstrual dysphoric disorders. New therapeutic strategies: our experience with Vitex agnus castus].Ciotta L, Pagano I, Stracquadanio M et al. · 2011 · Minerva ginecologica · PMID 21654609Open on PubMed
  9. Herbal treatments for alleviating premenstrual symptoms: a systematic review.Dante G, Facchinetti F · 2011 · Journal of psychosomatic obstetrics and gynaecology · PMID 21171936Open on PubMed
  10. Treatment of moderate to severe premenstrual syndrome with Vitex agnus castus (BNO 1095) in Chinese women.Ma L, Lin S, Chen R et al. · 2010 · Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology · PMID 20334585Open on PubMed
  11. Evaluating therapeutic effect in symptoms of moderate-to-severe premenstrual syndrome with Vitex agnus castus (BNO 1095) in Chinese women.Ma L, Lin S, Chen R et al. · 2010 · The Australian & New Zealand journal of obstetrics & gynaecology · PMID 20522079Open on PubMed
  12. Effects of a combination of Hypericum perforatum and Vitex agnus-castus on PMS-like symptoms in late-perimenopausal women: findings from a subpopulation analysis.van Die MD, Bone KM, Burger HG et al. · 2009 · Journal of alternative and complementary medicine (New York, N.Y.) · PMID 19757982Open on PubMed

04 / EXPERT CONTEXT

Expert context—not evidence

Expert positions are dated context—not scientific evidence. They never raise the evidence status or become consensus by repetition.

No direct, source-verified endorsement is currently recorded. Research authorship or discussion alone is not treated as endorsement.

Educational information only—not medical advice. Product quality, dose, medicines, pregnancy, and kidney or liver disease can materially change safety.